Amirhossein Niknejad

5PUBLICATIONS
21CO-AUTHORS
Molecular targetsAutoimmunityPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Biomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 26, 2026
Anti-diabetic drugs: a novel therapeutic approach against cisplatin-induced kidney injury, a mechanistic review of preclinical studies.

Amirhossein Niknejad, Yasamin Hosseini, Dietrich Büsselberg

|Oct 25, 2025
Therapeutic impacts of oral anti-diabetic drugs on Inflammatory Bowel Disease (IBD), a comprehensive review of clinical and preclinical studies.

Amirhossein Niknejad, Yasamin Hosseini, Mohammad Amin Nazari Manesh

|May 20, 2025
Phytochemicals Alleviate Tumorigenesis by Regulation of M1/M2 Polarization: A Systematic Review of the Current Evidence.

Amirhossein Niknejad, Niusha Esmaealzadeh, Amirreza Peyrovinasab

|Apr 21, 2024
Empagliflozin protective effects against cisplatin-induced acute nephrotoxicity by interfering with oxidative stress and inflammation in Wistar rats.

Nika Farrokh-Eslamlou, Saeideh Momtaz, Amirhossein Niknejad

|Sep 01, 2023
Sodium Glucose Transporter-2 Inhibitors (SGLT2Is)-TLRs Axis Modulates Diabetes.

Amirhossein Niknejad, Yasamin Hosseini, Hedieh Sadat Shamsnia

Pageof 1